baber/WOPTO huggingface dataset:
Patent CA-2184189-C (CA)
Title: Dental implant
Inventor: SHIMODA TSUNEHISA
IPC: A61B17/66
Filed: 1995-12-26
Granted: 2000-08-22
Abstract: A dental implant is provided that can be firmly fixed in an oral cavity, even if the amount of bone required to embed the implant is small. A necessary amount of bone can be provided by generating new bone so that the fixture part of the implant can be fixed in the bone. The fixture part of the implant includes several members which are movably connected to each other so that the fixture part is adjustable in length. The fixture part includes a first member which is made up of an uppermost member, a middle member, and an end member. It is preferred that the middle member be cylindrical or rod-shaped with male screws extending radially-outwardly from an outer circumferential periphery thereof. The fixture part also includes a second member which is a hollow cylinder. It is preferred that the hollow cylinder have a tapped hole on one end with female screw on an inner periphery thereof so that the middle member of the first member can be screwed into the second member. A continuous stimulating force which is formed by the embedment of the implant into bone and the lifting up of the mucous membrane by extending the fixture part of the implant, contributes to the osteogenesis around the implant
Patent CA-2185006-C (CA)
Inventor: LARSSON KAJ
IPC: G01B9/02
Filed: 1995-03-09
Granted: 2004-05-11
Abstract: Interféromètre comprenant un diviseur de faisceaux (BS) et deux miroirs de balayage (M1, M2) parallèles et disposés sur un élément coulissant commun pouvant se déplacer de manière linéaire. L'interféromètre comporte en outre deux miroirs compensateurs (M3, M4) placés entre le diviseur de faisceaux (BS) et les miroirs de balayage (M1, M2). Le diviseur de faisceaux (BS) et chacun des miroirs compensateurs (M3, M4) sont orthogonaux. L'interféromètre présente une bonne tolérance aux imprécisions de déplacement des miroirs de balayage (M1, M2). Il peut être utilisé pour obtenir un spectromètre de transformée de Fourier compacte et peu coûteux.
Patent CA-2186382-C (CA)
Title: Method and apparatus for diagnosing erectile dysfunction
Inventor: PLACE VIRGIL A
IPC: A61B8/06
Filed: 1995-03-20
Granted: 2001-09-11
Abstract: A method for diagnosing vasculogenic erectile dysfunction, including vasculogenic impotence and Peyronie's syndrome, is provided. The method involves transurethral administration of a vasodilating agent to induce an erection, followed by hemodynamic evaluation using duplex ultrasonography, NMR, angiography, or the like. Kits for conducting the diagnostic method are provided as well, as are methods of treatment based on the diagnostic conclusion. The kits for diagnosing erectile dysfunction comprise a vasodilating agent (4) effective to induce erection of the penis, a drug delivery means (1, 11, or 49) for administering the vasodilating agent transurethrally, a container (15 or 55) for housing the agent and drug delivery means, and written instructions for using the agent and the drug delivery means.
Patent CA-2188694-C (CA)
Title: Recipient rechargeable distribuant une matiere applicable, plus particulierement un compose adhesif
Inventor: FRANKEN JOACHIM
IPC: B65D83/00
Filed: 1995-04-18
Granted: 2005-11-29
Abstract: Le récipient (1) comporte un manchon intérieur (3) qui contient la matière applicable (4) et qui est monté amovible dans un manchon extérieur (5). Le manchon intérieur (3) est ouvert sur au moins un côté (2) et comprend un piston (12) traversé par une broche filetée (15). Le manchon intérieur comprend également un moyen d'assujettissement (6) pour le bloquer dans le manchon extérieur (5). La broche filetée (15) et le piston (12) forment ensemble des organes coopérants (11, 14) pour distribuer la matière applicable (4) qui se déplace axialement dans le sens longitudinal du récipient (1) par rotation de la broche filetée (15) qui s'engage dans un filetage interne (13) du piston (12) lorsque le manchon extérieur (5) et le manchon intérieur (3) se trouvent en position fixe l'un par rapport à l'autre. La broche filetée (15) est mise en rotation à l'aide d'un élément d'actionnement (21), notamment un écrou moleté (20) actionnable manuellement, disposé à l'extérieur du manchon extérieur (5). Dans une position dans laquelle elle traverse le piston (12), la broche filetée (15) est assujettie en rotation au manchon intérieur (3). La broche filetée (15) possède une partie de raccordement (17) qui dépasse notamment du manchon intérieur (3) et peut être accouplée de manière amovible et solidaire en rotation à une partie de raccordement correspondante (20) de l'élément d'actionnement (21). Le remplacement du manchon intérieur s'en trouve considérablement facilité.
Patent CA-2192188-C (CA)
Title: Cure-indicating molding and coating composition
Inventor: OXMAN JOEL D
IPC: A61K6/896
Filed: 1995-06-29
Granted: 2008-08-19
Abstract: The present invention provides novel hydrosilation-curable compositions, the cure of which can be monitored visually, comprising: (I) an ethylenic compound; (2) a compound containing silicon-bonded-hydrogen groups; (3) a hydrosilation catalyst; and (4) one or mo re cure-indicating dyes with light absorption in the visible spectrum that exhi bit a color change in the presence of a silicon-bonded-h ydrogen compound and a precious metal hydrosilation catalyst. The cure-indicating dy e provides the composition with an initial pre-cure colo r and a different post-cure color. As a result of this change in color, the state of cure of the composition can be visually monitored.
Patent CA-2202879-C (CA)
Inventor: MOE SCOTT T
IPC: C07C229/38
Filed: 1995-10-23
Granted: 2005-08-30
Abstract: The present invention features compounds of general formulae a), b), c), abl e to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. Preferably, the compound can mimic or block the effect of extracellular Ca2+ on a calcium receptor.
Patent CA-2203662-C (CA)
Inventor: UNGER PETER D
IPC: B60H3/06
Filed: 1995-12-19
Granted: 2000-12-19
Abstract: A filter device and technique are described which rely on absorption rather than adsorption for the removal of gas phase contaminants. A filter media (49) is composed of wicking fibers which are impregnated with any of a variety of liquid phase absorbing systems made from the combination of a carrier liquid and soluble complexing/degrading agent or agents. The wicking fibers may be connected to an external reservoir (37) which can be used to supply fresh absorbing fluid to the filter media giving them a potentially inexhaustible capacity. The filter media may be made from any of a variety of fibers which can rapidly transport a liquid phase by the nature of either their geometry or their chemical composition. Geometries may include multilobal cross-sectional configurations, porous hollow fibers, porous or striated fibers or tightly bundled microfibers, all of which exhibit the property of wicking fluid from an external source.
Patent CA-2205615-C (CA)
Inventor: UCHIKAWA AKIKO
IPC: G01S15/89
Filed: 1997-05-15
Granted: 2001-01-16
Abstract: A simple, compact and inexpensive ultrasonic wave diagnostic apparatus of electronic focus type in which the delay amount for controlling the phase of a transmission signal for each piezoelectric element is stored in a delay amount storage unit, the pulse width for controlling the frequency of the transmission signal for each piezoelectric element is stored in a pulse width storage unit, the time elapsed from a reference time point is counted by a counter, a change point of the transmission signal from the reference time point is calculated by a processor, the output of the processor is compared with the output of the counter by a comparator, a plurality of clocks having different phases are generated by a multiphase clock generator, a clock generated by the multiphase clock generator is selected by a selective controlle, and a pulse of the transmission signal is generated on the basis of the selected clock by a toggle circuit.  The delay amount, the duty factor and the frequency of the transmission signal are controlled for each piezoelectric element to converge the ultrasonic wave beam, thereby making possible a highly accurate diagnosis with high image quality.
Patent CA-2218172-C (CA)
Inventor: LECHTENBOHMER HANS NORBERT
IPC: E04H17/16
Filed: 1996-04-10
Granted: 2002-04-09
Abstract: Fence post (50) of a fence (100) of grid boards (20) comprising narrow, upright grid boards with upright rods (11, 12) and brackets (10) connecting these rods, which brackets project over the front side (13) of the fence post (50) with their free ends (3'). The grid boards (20) lie with horizontal rods (2, 2) on the projecting ends (3'). The projecting ends (3') form retaining elements (3) in the form of hooks that fasten the grid boards (20) at the front side (13) of the fence post (50).
Patent CA-2223212-C (CA)
Inventor: ICHIHARA MASAKI
IPC: H04B1/707
Filed: 1997-12-01
Granted: 2002-02-12
Abstract: In a CDMA multi-code transmitter in which data signals input from a plurality of data channels are spectrum-spread with mutually different spreading codes and resultant baseband signals are summed and transmitted, peak values of an eye-pattern are reduced in order to reduce power consumption. The reduction in peak values is achieved by delaying the baseband signals before they are summed, such that transmission timings of the respective baseband signals are mutually shifted.
Patent CA-2230672-C (CA)
Inventor: CHANDRARATNA ROSHANTHA A
IPC: A61K38/09
Filed: 1996-08-23
Granted: 2006-10-31
Abstract: Les dérivés de benzopyranne, de benzothiopyranne, de 1-2-dihydroquinoline, et de 5,6-dihydronaphtalène, substitués par aryle et éventuellement aryle et 3-oxo-1-propényle ont des activités biologiques d'antagonistes et/ou d'hormones négatives des rétinoïdes. On peut administrer les antagonistes des récepteurs RAR à des mammifères dont les humains, pour prévenir ou réduire l'action d'agonistes de RAR sur les sites de récepteurs liés. Plus spécifiquement, on administre ou co-administre les agonistes de RAR avec des médicaments à rétinoïdes pour empêcher ou atténuer la toxicité ou les effets secondaires des rétinoïdes, de la Vitamine A ou des précurseurs de la Vitamine A. On peut utiliser les hormones négatives de rétinoïdes pour amplifier les activités d'autres rétinoïdes et d'agonistes de récepteurs nucléaires. Par exemple, l'hormone négative de rétinoïdes appelée AGN 193109 augmente efficacement l'effet d'autres rétinoïdes et hormones stéroïdes dans des essais de transactivation in vitro. De plus, on peut utiliser les essais de transactivation pour identifier des composés ayant l'activité d'hormone négatives. Ces essais reposent sur la capacité des hormones négatives de rétro-réguler l'activité de récepteurs de rétinoïdes chimères manipulés de sorte qu'ils possèdent un domaine d'activateur de transcription constitutive.
Patent CA-2232288-C (CA)
Title: Treating niddm with rxr agonists
Inventor: HEYMAN RICHARD A
IPC: C07C63/49
Filed: 1996-09-17
Granted: 2010-02-23
Abstract: This invention relates to methods and compositions for the treatment of non-insulin-dependent diabetes mellitus using an RXR agonist alone or in combination with a PPAR.gamma. agonist such as a thiazolidinedione compound.
Patent CA-2233914-C (CA)
Title: Dispositif de connexion d'au moins deux fils conducteurs gaines
Inventor: LACROIX JACQUES
IPC: H01R4/24
Filed: 1996-09-26
Granted: 2003-02-11
Abstract: Le dispositif comprend un boîtier, avec un passage d'introduction d'une portion d'extrémité des fils gainés, un linguet de réception desdites portio ns d'extrémité dans le boîtier, un clip (12) agencé pour être introduit dans le  boîtier transversalement aux gaines, avec au moins deux fentes (13) pour saisir les gaines des fils et les tirer vers l'intérieur et le fond du boîti er et agencé pour coopérer avec le linguet pour dénuder les fils. Il est aussi prévu des moyens d'entretoise (52, 53) entre le linguet et le clip de saisie  et de tirage (12) pour maintenir leur écartement supérieur à un seuil de cou pe.
Patent CA-2237527-C (CA)
Inventor: TECZYNSKI STEFAN
IPC: G10K3/00
Filed: 1998-05-13
Granted: 2008-02-12
Abstract: The invention is a rattle particularly for use at sporting events to generate an interesting noise. The rattle is preferably manufactured by plastic injection moulding and has two components only, namely a handle and a rotor journalled for relative rotation therebetween. The handle has a grip portion, and a toothed portion remote from the grip portion and preferably the toothed portion is manufactured by moulding integrally with the grip portion. The rotor has at least one vane adapted to sweep the toothed portion as the rotor rotates relative thereto and is assembled onto the handle by passing the toothed portion axially. A retainer retains the rotor and handle together while permitting said relative rotation. Preferably, the toothed portion has two sets of teeth and the rotor has twin vanes to sweep respective teeth.
Patent CA-2240913-C (CA)
Inventor: LEYVA FERNANDO
IPC: A23L5/10
Filed: 1998-06-17
Granted: 2004-01-06
Abstract: A method for heating foodstuffs, particularly mixtures made up of small pieces of meat, comprises pressurizing the uncooked mixture to force the mixture through a flow resistance device (22) at a heating velocity. Sufficient force is applied to the uncooked mixture to produce frictional resistance heating in the uncooked mixture as the mixture travels through the flow resistance device (22). The frictional resistance heats the uncooked mixture from an initial temperature to a final temperature which may be above a cooking temperature. This final temperature converts the uncooked mixture to a desired processed mixture. The invention may also include forming the processed mixture into a desired shape and cooling the processed mixture to a setting temperature. A variable resistance device (40) may be included in the flow resistance device (22) and used to control the level of heating in the foodstuffs.
Patent CA-2241947-C (CA)
Title: Cartouche contenant deux liquides
Inventor: LAGUNA VALDERRAMA JOSE MA
IPC: A61J1/05
Filed: 1998-07-15
Granted: 2003-10-21
Abstract: Cartouche pouvant contenir deux liquides, caractérisée par le fait d'être constituée par deux moitiés, les deux cylindriques reliées longitudinalement et pourvues, aux extrémités opposées à celles par lesquelles elles sont unies entre elles, de deux bouchons à pression pourvus d'une zone débilitée centrale qui, fermant l'ensemble, permet d'être traversée, tandis qu'à l'extrémité opposée, l'une des moitiés présente un tube longitudinal aux parois fines, en correspondance avec une membrane pouvant être déchirée, fixée sur la moitié opposée, qui demeure appuyée contre l'extrémité dudit tube, tout pendant qu'il existe une bande de sûreté et que les liquides contenus dans la cartouche ne sont pas utilisés.
Patent CA-2242634-C (CA)
Inventor: DUTTON DAVID THOMAS
IPC: G02B3/00
Filed: 1997-01-09
Granted: 2006-08-15
Abstract: A method of forming three-dimensional structures on a substrate by a single reactive ion etch run whereby a mask is formed on said substrate before a series of iterations are carried out, each iteration including a mask etch and a substrate etch, so that successive iterations give rise to reduction in the mask area and exposure of further areas of substrate.
Patent CA-2242915-C (CA)
Inventor: REYNOLDS DAVID L
IPC: A61J1/00
Filed: 1997-01-10
Granted: 2001-08-21
Abstract: A system is provided for providing syringes filled with pharmaceuticals whose components must be stored separately, using an active ingredient in a pharmaceutical vial (2), a diluent in a protosyringe such as a bottomless vial (4) or a cartridge, and a combiner assembly which enables the content of the pharmaceutical vial to be transferred into the protosyringe and converts it into a ready-to-use syringe on activation. The combined assembly included a tubular body (22, 24) having recesses (30, 31) at opposite ends for receiving capped ends of the vial (2) and the protosyringe (4), and a hub (34) and needle (40, 44) assembly between penetrable sheaths or shields (46, 64) which acts on activation of the assembly to enable the transfer and conversion referred to above. Components of the system may also be used to convert protosyringes and pharmaceutical vials containing pharmaceuticals into delivery systems.
Patent CA-2247516-C (CA)
Title: Organic waste processing method and plant, and uses of said method
Inventor: LASSEUR CHRISTOPHE ANDRE ANTOI
IPC: C12S3/00
Filed: 1997-02-20
Granted: 2007-11-27
Abstract: An open-circuit organic waste processing method, a plant therefor, and the uses of said method, are disclosed. The processing method comprises (a) collecting the waste, (b) feeding the waste into a first reactor without prior sterilisation, (c) decomposing the waste in said reactor by means of mesophilic or thermophilic anaerobic bacteria, (d) recovering the resulting liquid effluent and transferring it into a second reactor containing heterotrophic or photoheterotrophic bacteria, (e) using the heterotrophic or photoheterotrophic bacteria to produce an edible biomass consisting of said bacteria, and (f) recovering and packaging the resulting biomass. The method is particularly suitable for recycling organic animal waste such as liquid manure or water purification sludge.
Patent CA-2256348-C (CA)
Title: Methode pour ameliorer les problemes cutanes
Inventor: CIOCA GHEORGHE
IPC: A61K8/00
Filed: 1997-05-13
Granted: 2002-07-23
Abstract: Méthode pour améliorer les problèmes cutanés en administrant à la peau un substrat physiologiquement acceptable qui a été exposé à un champ magnétique à potentiel vectoriel et qui contient une énergie d'information.
Patent CA-2263336-C (CA)
Title: Neuraminic acid compounds
Inventor: YAMASHITA MAKOTO
IPC: A61P31/16
Filed: 1997-08-12
Granted: 2007-03-13
Abstract: [Constitution] A neuraminic acid compound represented by the formula: (see formula 1) [wherein R1 represents a C1-C4 group which may be substituted with a halogen atom; R2, R3 and R4 may be the same or different and each represents a hydrogen at om or a C3-C25 aliphatic acyl group; and W represents a hydrogen atom or an ester residue, provided that the case where R1 is a methyl group and each of R2, R3, R4 and W is a hydrogen atom is excluded] or a pharmacologically acceptable salt thereof. [Effect] The neuraminic acid compound of the present invention exhibits excellent in vivo sialidase inhibitory activity and is useful as a therapeutic agent or a preventive agent for influenza viral infections.
Patent CA-2268357-C (CA)
Title: High-speed driving method of a liquid crystal
Inventor: OKITA MASAYA
IPC: G09G3/36
Filed: 1999-04-08
Granted: 2010-06-22
Abstract: In order to drive a liquid crystal at a speed equivalent to or higher than CRT displays, in a liquid crystal display device made of a liquid crystal and two electrodes sandwiching the liquid crystal to display images by applying a voltage based on gradation data between the two electrodes, a predetermined voltage independent from the gradation data is applied across the two electrodes for a predetermined length of time in predetermined intervals.
Patent CA-2270932-C (CA)
Title: Pull back stent delivery system with pistol grip retraction handle
Inventor: SULLIVAN ROY III
IPC: A61F2/966
Filed: 1997-11-12
Granted: 2007-01-16
Abstract: A stent delivery system for delivering a self-expanding stent to a predetermined location in a vessel includes a catheter body having an axial guidewire lumen and a pull-wire lumen. A medical device such as a self-expanding stem is held in a reduced delivery configuration for insertion and transport through a body lumen to a predetermined site for deployment. The stent is carried axially around the catheter body near its distal end and held in its reduced configuration by a retractable outer sheath. A proximal retraction handle is connected to the proximal end of the catheter body and includes a pistol grip trigger engaging a racket mechanism, which is connected to a pull-wire which extends through the pull-wire lumen and is connected to the retractable outer sheath.
Patent CA-2271762-C (CA)
Inventor: CAVALIERE WIDOW VESELY RENATA MARIA ANNA
IPC: A61K8/68
Filed: 1997-11-14
Granted: 2011-03-15
Abstract: La présente invention concerne l'utilisation de la sphingomyélinase afin d'augmenter la teneur en céramides de la peau et des muqueuses. L'invention concerne également des compositions dermatologiques et cosmétiques à base de sphingomyélinase et s'utilisant en application locale.
Patent CA-2275679-C (CA)
Inventor: COX JIMMY ARTHUR
IPC: B23B51/00
Filed: 1999-06-17
Granted: 2010-01-05
Abstract: A method for manufacturing machining tools out of composite powdered metal which is first formed to approximate the desired shape of the machining tool; then bonded metallurgically; and machined to the desired finished shape. Desirably, the forming step employs at least two distinct powdered metals, the first formed to the outer shape over the portion of the tool that interfaces with the work piece and selected to exhibit the desired hardness and wear-resistance properties. The second material supports the hollow form of the first material and includes a shank to interface with the machine that the tool will be employed with. The second material is chosen to exhibit the desired ductility, surface hardness, abrasion resistance and reduced cost. Additional materials can be used for different facets of the tool to obtain an optimum balance of long life, efficient operation and low cost.
Patent CA-2279615-C (CA)
Inventor: MCCREERY PATRICK A
IPC: F02B75/16
Filed: 1999-08-04
Granted: 2005-02-08
Abstract: A starting system for a manual only pull start internal combustion engine with a starting pulley, a pull cord wrapped around the starting pulley, a rotor selectively engageable with the starting pulley, and an ignition module located adjacent to the rotor. The starting pulley has a pull cord groove with an enlarged diameter between about 2.5 and 3.4 inches. The ignition module a.s adapted to fire a spark plug of the engine with a timing retard of about 8 degrees at a speed of about 500 rpm of the rotor.
Patent CA-2283101-C (CA)
Title: Quinoline leukotriene antagonists
Inventor: BAILLIE THOMAS A
IPC: A61K31/47
Filed: 1998-03-10
Granted: 2008-01-22
Abstract: Compounds of formula (I) are antagonists of the actions of leukotrienes. The se compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treati ng angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Patent CA-2285009-C (CA)
Inventor: HILDRUM RAGNE
IPC: C01B31/02
Filed: 1998-03-20
Granted: 2008-03-18
Abstract: Cette invention concerne un procédé de production de matériaux graphitiques à micro-domaines par l'utilisation d'un traitement au plasma, et de nouveaux matériaux graphitiques microconiques. Par matériaux graphitiques à micro-domaines nous entendons des fullerènes, des nanotubes en carbone, des structures en carbone coniques ouvertes (également appelées microcones), des plaques graphitiques de préférence planes ou un mélange constitué de deux de ces éléments ou de tous ces éléments. Le nouveau matériau en carbone se compose de microcones en carbone ouverts avec des degrés de désinclinaison totale de 60 DEG  et/ou 120 DEG , correspondant aux angles des cones respectivement de 112,9 DEG  et/ou 83,6 DEG .